Yield10 Bioscience

Yield10 Bioscience Cash Conversion

The Cash Conversion Rate (OCF/Net Income) of Yield10 Bioscience (YTENQ) as of Nov 3, 2026 is 69.65 %. In the previous year, Cash Conversion Rate (OCF/Net Income) was 84.06 % — a change of -17.14% (lower).

Cash Conversion

69.65 %

YoY

-17.14%

Last updated:

Cash Conversion Rate (OCF/Net Income) of Yield10 Bioscience is 2023 69.65 % . Cash Conversion Rate (OCF/Net Income) of Yield10 Bioscience was 2022 84.06 % . It decreases by -17.14% lower compared to the previous year.

The Yield10 Bioscience Cash Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion
Date
Cash Conversion
Jan 1, 2016
193.42 USD
Jan 1, 2017
75.79 USD
Jan 1, 2018
95.21 USD
Jan 1, 2019
66.74 USD
Jan 1, 2020
84.84 USD
Jan 1, 2021
83.88 USD
Jan 1, 2022
84.06 USD
Jan 1, 2023
69.65 USD
The Yield10 Bioscience Cash Conversion history
YEARCash ConversionYoY
69.65 %-17.14%
84.06 %+0.22%
83.88 %-1.13%
84.84 %+27.12%
66.74 %-29.90%
95.21 %+25.63%
75.79 %-60.82%
193.42 %+109.52%
92.31 %+11.09%
83.10 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Yield10 Bioscience Stock analysis

What does Yield10 Bioscience do? Yield10 Bioscience develops Camelina sativa as a platform crop for low carbon sustainable seed products, including Camelina oil for biofuel feedstock, Omega-3 oils for nutrition, and PHA Bioplastics for biodegradable packaging. The company uses its TraitFactory platform to discover genetic traits for agriculture and food industries, focusing on herbicide tolerance and disease resistance in Camelina germplasm. Its products target petroleum replacement markets, food and nutrition sectors, and animal feed markets, with development pipelines focused on improving Camelina varieties. The company's primary products are Camelina oil, Omega-3 oils, and PHA Bioplastics, sold to markets addressing petroleum replacement, nutrition, and sustainable packaging needs. Camelina sativa serves as the core crop for all seed product development, with TraitFactory enabling trait discovery for agricultural and food applications. The firm targets industrial buyers in biofuel, nutrition, and packaging industries seeking sustainable alternatives to petroleum-based products. Yield10 Bioscience's revenue streams come from the sale of Camelina-based products to companies in the biofuel, nutrition, and packaging sectors. The company focuses on developing high-value genetic traits through TraitFactory, which are integrated into Camelina varieties for large-scale production of seed products. Its development pipeline emphasizes traits like herbicide tolerance and disease resistance to enhance crop performance and market appeal. Yield10 Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Yield10 Bioscience stock

Cash Conversion Rate (OCF/Net Income) of Yield10 Bioscience is 69.65 % in 2023.

Cash Conversion Rate (OCF/Net Income) of Yield10 Bioscience changed from 84.06 % to 69.65 %, representing a -17.14% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Rate (OCF/Net Income) Yield10 Bioscience since 2006 – with annual values, charts, and detailed analysis.

Cash conversion measures how effectively net income converts to operating cash flow. Ratios above 100% indicate high-quality, cash-backed earnings.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Rate (OCF/Net Income)'s Yield10 Bioscience with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Rate (OCF/Net Income)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Rate (OCF/Net Income).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Yield10 Bioscience

All Key Metrics — Yield10 Bioscience